SCHEMBL6536476

SCHEMBL6536476

CCC1(N)NC(=O)c2nc[nH]c2N1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL214954 0.88
SCHEMBL28603365 0.83
SCHEMBL8541874 0.82 CDK1 (0.32)
SCHEMBL21835 0.78 MEN1 (0.30) MEN1BLMKMT2A
SCHEMBL3305619 0.78 ALDH1A1 (0.31)
SCHEMBL28757165 0.77 LMNA (0.30)
SCHEMBL8742 0.75
SCHEMBL6681441 0.73
SCHEMBL4267183 0.69
SCHEMBL4741585 0.69 ALDH1A1 (0.35) BLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998596-A Inhibition of protein kinase activity by aptameric action of oligonucleotides THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-07 US claimed
US-20040170990-A1 Intracellular nucleic acid inhibitors of small guanine nucleotide exchange factors WALDEMAR KOLANUS (DE) 2004-09-02 US disclosed
EP-1290142-A4 SHORT-ROOT GENE, PROMOTER, AND USES THEREOF UNIV NEW YORK (US) 2004-06-16 EP disclosed
WO-2003094973-A1 AGENT AND METHOD FOR TRANSPORTING BIOLOGICALLY ACTIVE MOLECULES IN CELLS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2003-11-20 WO disclosed
EP-1333090-A1 Prionprotein-specific aptamers NascaCell GmbH (DE) 2003-08-06 EP disclosed
EP-1290142-A1 SHORT-ROOT GENE, PROMOTER, AND USES THEREOF NEW YORK UNIVERSITY (US) 2003-03-12 EP disclosed
WO-2002081686-A2 NUCLEIC ACIDS BINDING A NEUROPEPTIDE NASCACELL GMBH (DE) 2002-10-17 WO disclosed
EP-1223216-A1 Intracellular nucleic acid inhibitors of small guanine-nucleotide-exchange factors NascaCell GmbH (DE) 2002-07-17 EP disclosed
WO-2002053731-A1 INTRACELLULAR NUCLEIC ACID INHIBITORS OF SMALL GUANINE NUCLEOTIDE EXCHANGE FACTORS NASCACELL GMBH (DE) 2002-07-11 WO disclosed
WO-2002026955-A2 HUMAN PROTEASES AND POLYNUCLEOTIDES ENCODING THE SAME LEXICON GENETICS INCORPORATED (US) 2002-04-04 WO disclosed
WO-2001090314-A1 SHORT-ROOT GENE, PROMOTER, AND USES THEREOF NEW YORK UNIVERSITY (US) 2001-11-29 WO disclosed
US-5998596-A Inhibition of protein kinase activity by aptameric action of oligonucleotides THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-07 US disclosed
EP-0691968-B1 ACYCLIC NUCLEOSIDE ANALOGS AND OLIGONUCLEOTIDE SEQUENCES CONTAINING THEM SANOFI SA (FR) 1997-07-16 EP disclosed
US-5576427-A COMPOUNDS WHICH REPLACE NUCLEOSIDES IN AN OLIGONUCLEOTIDE TO INHIBIT NUCLEASE DEGRADATION OF OLIGONUCLEOTIDE STERLING WINTHROP, INC. (US) 1996-11-19 US disclosed
WO-1994022864-A1 ACYCLIC NUCLEOSIDE ANALOGS AND OLIGONUCLEOTIDE SEQUENCES CONTAINING THEM STERLING WINTHROP INC. (US) 1994-10-13 WO disclosed
US-5256775-A Having two or more phosphoramidiate linkages GILEAD SCIENCES, INC. (US) 1993-10-26 US disclosed
EP-0476071-A4 EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME 1992-11-04 EP disclosed
EP-0476071-A1 EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME GILEAD SCIENCES, INC. (US) 1992-03-25 EP disclosed
WO-1990015065-A1 EXONUCLEASE-RESISTANT OLIGONUCLEOTIDES AND METHODS FOR PREPARING THE SAME GILEAD SCIENCES, INC. (US) 1990-12-13 WO disclosed